Login / Signup
Xuewei Zhai
ORCID
Publication Activity (10 Years)
Years Active: 2022-2022
Publications (10 Years): 5
Top Topics
Cell Death
Drug Administration
Fatty Acid
Endoplasmic Reticulum Stress
Top Venues
The Journal of experimental medicine
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Qiaoyun Chu
,
Jing An
,
Ping Liu
,
Yihan Song
,
Xuewei Zhai
,
Rong-Hui Yang
,
Jing Niu
,
Chuanzhen Yang
,
Binghui Li
Repurposing a tricyclic antidepressant in tumor and metabolism disease treatment through fatty acid uptake inhibition.
The Journal of experimental medicine
220 (3) (2022)
Qiaoyun Chu
,
Jing An
,
Ping Liu
,
Yihan Song
,
Xuewei Zhai
,
Rong-Hui Yang
,
Jing Niu
,
Chuanzhen Yang
,
Binghui Li
Repurposing a tricyclic antidepressant in tumor and metabolism disease treatment through fatty acid uptake inhibition.
The Journal of experimental medicine
220 (3) (2022)
Qiaoyun Chu
,
Jing An
,
Ping Liu
,
Yihan Song
,
Xuewei Zhai
,
Rong-Hui Yang
,
Jing Niu
,
Chuanzhen Yang
,
Binghui Li
Repurposing a tricyclic antidepressant in tumor and metabolism disease treatment through fatty acid uptake inhibition.
The Journal of experimental medicine
220 (3) (2022)
Qiaoyun Chu
,
Jing An
,
Ping Liu
,
Yihan Song
,
Xuewei Zhai
,
Rong-Hui Yang
,
Jing Niu
,
Chuanzhen Yang
,
Binghui Li
Repurposing a tricyclic antidepressant in tumor and metabolism disease treatment through fatty acid uptake inhibition.
The Journal of experimental medicine
220 (3) (2022)
Qiaoyun Chu
,
Jing An
,
Ping Liu
,
Yihan Song
,
Xuewei Zhai
,
Rong-Hui Yang
,
Jing Niu
,
Chuanzhen Yang
,
Binghui Li
Repurposing a tricyclic antidepressant in tumor and metabolism disease treatment through fatty acid uptake inhibition.
The Journal of experimental medicine
220 (3) (2022)